These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 29554595
1. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma. Zhang Y, Meng W, Cui H. Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595 [Abstract] [Full Text] [Related]
2. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma. Chen S, Li W, Guo A. Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30944201 [Abstract] [Full Text] [Related]
3. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X, Xiong Y, Tang F, Bian Y, Chen Y, Zhang F. Biomed Pharmacother; 2017 Dec 30; 96():877-883. PubMed ID: 29145164 [Abstract] [Full Text] [Related]
5. LncRNA CBR3-AS1 predicts a poor prognosis and promotes cervical cancer progression through the miR-3163/LASP1 pathway. Cai Y, Huang Y, Zhang J, Liu X, Zhao F, Zhang K, Xu S, Yang Y, Huang H, Gao Y. Neoplasma; 2022 Dec 30; 69(6):1406-1417. PubMed ID: 36591804 [Abstract] [Full Text] [Related]
7. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142. Yang G, Song R, Wang L, Wu X. Biomed Pharmacother; 2018 Jul 30; 103():1238-1245. PubMed ID: 29864904 [Abstract] [Full Text] [Related]
8. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma. Ye H, Lin J, Yao X, Li Y, Lin X, Lu H. Cell Physiol Biochem; 2018 Jul 30; 45(5):1904-1914. PubMed ID: 29518771 [Abstract] [Full Text] [Related]
9. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer. Wang F, Ni H, Sun F, Li M, Chen L. Biomed Pharmacother; 2016 Jul 30; 81():152-159. PubMed ID: 27261589 [Abstract] [Full Text] [Related]
11. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma. Qu Y, Zheng S, Kang M, Dong R, Zhou H, Zhao D, Zhao J. Biomed Pharmacother; 2018 Feb 30; 98():899-906. PubMed ID: 29571260 [Abstract] [Full Text] [Related]
12. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma. Wang Y, Zhao Z, Zhang S, Li Z, Li D, Yang S, Zhang H, Zeng X, Liu J. J Cell Biochem; 2018 Nov 30; 119(10):8481-8489. PubMed ID: 29987852 [Abstract] [Full Text] [Related]
13. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway. Zhang M, Wang Y, Jiang L, Song X, Zheng A, Gao H, Wei M, Zhao L. J Exp Clin Cancer Res; 2021 Jan 25; 40(1):41. PubMed ID: 33494806 [Abstract] [Full Text] [Related]
15. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2. Gu W, Zhang E, Song L, Tu L, Wang Z, Tian F, Aikenmu K, Chu G, Zhao J. Biomed Pharmacother; 2018 Oct 25; 106():890-895. PubMed ID: 30119259 [Abstract] [Full Text] [Related]
16. PlncRNA-1 is overexpressed in retinoblastoma and regulates retinoblastoma cell proliferation and motility through modulating CBR3. Wang S, Liu J, Yang Y, Hao F, Zhang L. IUBMB Life; 2018 Oct 25; 70(10):969-975. PubMed ID: 30096220 [Abstract] [Full Text] [Related]
18. CDKN2B-AS1 Exerts Oncogenic Role in Osteosarcoma by Promoting Cell Proliferation and Epithelial to Mesenchymal Transition. Luo Y, Tao H, Jin L, Xiang W, Guo W. Cancer Biother Radiopharm; 2020 Feb 25; 35(1):58-65. PubMed ID: 31724892 [Abstract] [Full Text] [Related]